Outpace Bio to present new data on programmed CAR T cell candidate OPB-101 at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 05, 2024 09:00 ET
|
Outpace Bio
Outpace Bio at SITC 2024: AI-powered OPB-101 CAR T cells show lasting functional persistence, enhanced anti-tumor activity, & stem central memory phenotype
Protein Engineering Industry to Cross $7.8 Billion by 2030 - Discover the Key Trends, Drivers, and Market Players Shaping the Future Landscape
June 19, 2024 04:07 ET
|
Research and Markets
Dublin, June 19, 2024 (GLOBE NEWSWIRE) -- The "Protein Engineering - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Protein...
Global 3D Protein Structure Analysis Market 2023 to 2027: Rising Focus on Automation and Miniaturization in X-Ray Crystallography Workflow Drives Growth
July 07, 2023 04:43 ET
|
Research and Markets
Dublin, July 07, 2023 (GLOBE NEWSWIRE) -- The "3D Protein Structure Analysis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027" report has been added to ...
Global Protein Engineering Market Trends & Analysis Report 2023-2030: Rising Demand for Non-chemical Medicinal Alternatives for the Treatment of Chronic Diseases
June 01, 2023 10:43 ET
|
Research and Markets
Dublin, June 01, 2023 (GLOBE NEWSWIRE) -- The "Protein Engineering Market Size, Share & Trends Analysis Report By Product (Reagents, Instruments), By Protein Type (Insulin, Vaccines), By End-use...
Outpace Bio Expands Seattle Presence with Cell Therapy Research Hub & Collaborations with Leading Experts in Protein Design & Cancer Immunotherapy
May 22, 2023 08:00 ET
|
Outpace Bio
Seattle, WA, May 22, 2023 (GLOBE NEWSWIRE) -- Outpace Bio, a company using protein design and cell engineering to create advanced cell therapies with curative potential, today announced the...
Outpace Bio to Present New Data on OutSmart™ IL-2/15, a CAR T Cell-Produced Designed Cytokine with Tumor-Localized Immune Cell Activity, at the 2023 Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
May 18, 2023 08:00 ET
|
Outpace Bio
Seattle, WA, May 18, 2023 (GLOBE NEWSWIRE) -- Outpace Bio, a company using protein design and cell engineering to create advanced cell therapies with curative potential, today announced it will...
Outpace Bio, a Leader in Protein Design for Cell Therapy, Announces Presentation at the 2023 Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
May 09, 2023 09:00 ET
|
Outpace Bio
Seattle, WA, May 09, 2023 (GLOBE NEWSWIRE) -- Outpace Bio, a company using protein design and cell engineering to create advanced cell therapies with curative potential, today announced that an...
Outpace Bio, a Leader in Protein Design for Cell Therapy, Strengthens Executive Leadership Team with Key Appointments
May 04, 2023 08:00 ET
|
Outpace Bio
Seattle, WA, May 04, 2023 (GLOBE NEWSWIRE) -- Outpace Bio, a company using protein design and cell engineering to create advanced cell therapies, today announced two key leadership appointments....
Global Protein Engineering Market (2022 to 2027) - Featuring Bio-Rad Laboratories, Bruker, Codexis and Creative Biolabs Among Others
September 14, 2022 08:03 ET
|
Research and Markets
Dublin, Sept. 14, 2022 (GLOBE NEWSWIRE) -- The "Global Protein Engineering Market (2022-2027) by Product & Service, Protein Type, Technology, End User, Geography, Competitive Analysis, and the...
Outlook on the Synthetic Biology: Protein Design and Engineering Global Market to 2035 - Industry Trends and Forecasts
March 16, 2022 07:48 ET
|
Research and Markets
Dublin, March 16, 2022 (GLOBE NEWSWIRE) -- The "Synthetic Biology: Protein Design and Engineering Market by Type of Protein Engineering Approach Used, Type of Protein, Type of Application, Type of...